SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,604.00    18.00 (0.39%)
Bid:
4,602.00
Ask:
4,606.00
Spread: 4.00 (0.087%)
Market Cap: £16.78b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

9 Nov 2023 15:20

RNS Number : 9922S
Coca-Cola HBC AG
09 November 2023
 

FOR IMMEDIATE RELEASE

09 November 2023

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company has been notified that the following PDMR exercised share options and sold corresponding ordinary shares of CHF 6.70 each in the Company on 08 November 2023.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

JAAK MIKKEL

2

 

Reason for the notification

a)

 

Position/status

 

NEW BUSINESS DIRECTOR

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

DUE TO UPCOMING EXPIRATION, EXERCISE OF 10,618 SHARE OPTIONS AT THE STRIKE PRICE OF GBP 16.00 AND SUBSEQUENT SALE OF SHARES AT GBP 21.089665 PER SHARE RESULTING IN THE NET AMOUNT OF APPROX GBP 53,314

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

21.089665 GBP

10,618

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

21.089665 GBP

10,618

223,930.06 GBP

e)

 

Date of the transaction

 

2023-11-08

 

f)

 

Place of the transaction

 

XLON

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKCBDPBDDCDK
Date   Source Headline
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:42 amRNSAthens Exchange trading date of ordinary shares
1st Jun 20177:54 amRNSIssue of Equity and Total Voting Rights
19th May 201712:24 pmRNSDirector/PDMR Shareholding
16th May 20177:11 amRNSNotice of AGM
15th May 20177:23 amRNSchange to the Board and confirms dividend dates
11th May 20177:00 amRNSYEAR STARTS WELL WITH GOOD REVENUE GROWTH
2nd May 20179:07 amRNSIssue of Equity and Total Voting Rights
2nd May 20178:48 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.